Boehringer's Pradaxa price higher than forecast

Germany's Boehringer Ingelheim priced its new stroke prevention pill Pradaxa at $6.75 a day, higher than the $6 some analysts had expected. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.